BILIARY ATRESIA
Clinical trials for BILIARY ATRESIA explained in plain language.
Never miss a new study
Get alerted when new BILIARY ATRESIA trials appear
Sign up with your email to follow new studies for BILIARY ATRESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug could delay liver transplants in kids with rare bile duct disease
Disease control OngoingThis study tests a drug called odevixibat in children with biliary atresia, a rare liver disease where bile ducts are blocked. All children have already had a Kasai surgery to help bile flow. The goal is to see if odevixibat can delay or prevent the need for a liver transplant an…
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated May 26, 2026 04:47 UTC
-
New hope for kids with rare liver disease: drug may delay transplant
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety and effectiveness of odevixibat in children with biliary atresia, a rare liver disease. The main goal is to see if the drug helps children stay alive without needing a liver transplant. About 180 children who completed a previous study will t…
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Researchers dig into 150 medical records to unlock secrets of rare liver disease
Knowledge-focused OngoingThis study looks back at the medical records of 150 children with biliary atresia, a rare liver disease, treated between 2012 and 2021. Researchers want to find out which treatments and factors lead to better outcomes, such as avoiding liver transplants. The goal is to use this i…
Matched conditions: BILIARY ATRESIA
Sponsor: Yale University • Aim: Knowledge-focused
Last updated May 26, 2026 04:52 UTC